MedPath

Biogen

Biogen logo
🇺🇸United States
Ownership
Private
Established
1978-01-01
Employees
7.5K
Market Cap
$29.6B
Website
https://www.biogen.com
Introduction

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012

Phase 3
Completed
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
First Posted Date
2015-10-20
Last Posted Date
2017-04-27
Lead Sponsor
Biogen
Target Recruit Count
221
Registration Number
NCT02579681
Locations
🇮🇹

Research site, Roma, Italy

Brimonidine Tartrate for the Treatment of Injection Related Erythema

Phase 4
Withdrawn
Conditions
Relapsing-Remitting Multiple Sclerosis (RRMS)
Interventions
First Posted Date
2015-10-05
Last Posted Date
2016-04-25
Lead Sponsor
Biogen
Registration Number
NCT02568111

Single Ascending Doses of BIIB063 in Healthy Volunteers

Phase 1
Terminated
Conditions
Healthy
Interventions
Biological: BIIB063
Other: Placebo
First Posted Date
2015-09-21
Last Posted Date
2017-04-18
Lead Sponsor
Biogen
Target Recruit Count
29
Registration Number
NCT02555085
Locations
🇬🇧

Research Site, Leeds, West Yorkshire, United Kingdom

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase 3
Completed
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
First Posted Date
2015-09-21
Last Posted Date
2019-11-22
Lead Sponsor
Biogen
Target Recruit Count
20
Registration Number
NCT02555215
Locations
🇹🇷

Research Site, Ankara, Turkey

Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2015-09-16
Last Posted Date
2017-10-16
Lead Sponsor
Biogen
Target Recruit Count
36
Registration Number
NCT02551497
Locations
🇬🇧

Research Site, Nottingham, United Kingdom

Systemic Sclerosis Clinical and Biomarker Study

Withdrawn
Conditions
Healthy
Systemic Sclerosis
First Posted Date
2015-08-21
Last Posted Date
2015-11-01
Lead Sponsor
Biogen
Registration Number
NCT02531009

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Phase 3
Completed
Conditions
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Interventions
First Posted Date
2015-08-18
Last Posted Date
2019-06-27
Lead Sponsor
Biogen
Target Recruit Count
218
Registration Number
NCT02525874
Locations
🇹🇷

Research Site, Umuttepe, Kocaeli, Turkey

Single-Dose Study of a New Formulation of BIIB061

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2015-08-13
Last Posted Date
2015-09-07
Lead Sponsor
Biogen
Target Recruit Count
8
Registration Number
NCT02521545
Locations
🇺🇸

Research Site, Madison, Wisconsin, United States

Tecfidera Lymphocyte Chart Review

Completed
Conditions
Multiple Sclerosis
First Posted Date
2015-08-10
Last Posted Date
2016-08-26
Lead Sponsor
Biogen
Target Recruit Count
483
Registration Number
NCT02519413
Locations
🇺🇸

Research site, Homewood, Alabama, United States

🇺🇸

Research Site, Milwaukee, Wisconsin, United States

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Phase 3
Terminated
Conditions
Alzheimer's Disease
Interventions
First Posted Date
2015-06-29
Last Posted Date
2021-09-02
Lead Sponsor
Biogen
Target Recruit Count
1643
Registration Number
NCT02484547
Locations
🇺🇸

Lehigh Center for Clinical Research, LLC, Allentown, Pennsylvania, United States

🇺🇸

Syrentis Clinical Research, Santa Ana, California, United States

🇺🇸

Hattiesburg Clinic, PA, Hattiesburg, Mississippi, United States

and more 152 locations
© Copyright 2025. All Rights Reserved by MedPath